AI in healthcare faces Medicare Advantage scrutiny

Medicare Advantage plans are now under bipartisan scrutiny in the US Congress, specifically concerning their use of artificial intelligence to manage and, in some cases, deny patient care. Legislators are questioning whether algorithms are leading to inappropriate denials of medically necessary services, raising significant concerns about patient well-being and access to care.

This pressure follows reports of pervasive use of AI tools to predict and limit healthcare service authorizations. For example, a 2023 New York Times investigation detailed how some insurers use AI to project when a patient’s health might improve, leading to premature termination of coverage for services like rehabilitation. This practice often overrides medical professionals' judgments, creating substantial hurdles for patients seeking continued treatment.

The Centers for Medicare & Medicaid Services (CMS) has already issued guidance to Medicare Advantage plans, emphasizing that AI tools must not be used to issue blanket denials for care. However, the exact mechanisms and impact of current AI applications remain opaque, prompting calls for more robust oversight and regulatory clarity.

For individuals managing their wellness, this debate highlights the importance of understanding their rights regarding medical care and advocating when AI-driven decisions seem to conflict with their needs. It calls for active engagement with healthcare providers to question and, if necessary, appeal denials that may be algorithmically rather than medically driven.